cannabidiol (BTX 1702) / Botanix Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cannabidiol (BTX 1702) / Botanix Pharma
ACTRN12621000689875: A Randomised, Double-Blind, Vehicle-Controlled Study of the Safety and Tolerability of BTX 1702 in Patients with Papulopustular Rosacea

Completed
1
120
 
Botanix Pharmaceuticals Ltd, Botanix Pharmaceuticals Ltd
Papulopustular Rosacea
 
 

Download Options